Provided by Tiger Trade Technology Pte. Ltd.

Bausch + Lomb Corp.

17.28
-0.4500-2.54%
Volume:300.34K
Turnover:5.15M
Market Cap:6.12B
PE:-20.01
High:17.69
Open:16.76
Low:16.25
Close:17.73
52wk High:17.91
52wk Low:10.45
Shares:354.19M
Float Shares:42.05M
Volume Ratio:1.48
T/O Rate:0.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8635
EPS(LYR):-0.9011
ROE:-4.50%
ROA:0.53%
PB:0.95
PE(LYR):-19.18

Loading ...

Stock Track | Bausch + Lomb Plummets 5.47% Intraday Following Q4 Earnings Miss

Stock Track
·
Yesterday

Bausch + Lomb Q4 Adjusted EBITDA USD 326 Million Vs. IBES Estimate USD 320.4 Million

Reuters
·
Yesterday

Bausch + Lomb Q4 revenue beats estimates, helped by Vision Care segment

Reuters
·
Yesterday

GUIDANCE: (BLCO) Bausch + Lomb Expects 2026 Revenue Range $5.38B - $5.48B, vs. FactSet Est of $5.39B

MT Newswires Live
·
Yesterday

Bausch & Lomb Q4 Adj. EPS $0.32 Misses $0.35 Estimate, Sales $1.405B Beat $1.381B Estimate

Benzinga
·
Yesterday

Bausch + Lomb Q4 Pharmaceuticals revenue jumps 16% to USD 378 million

Reuters
·
Yesterday

Stifel Nicolaus Keeps Their Hold Rating on Bausch + Lomb Corporation (BLCO)

TIPRANKS
·
Feb 17

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Feb 17

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Feb 13

How Bausch + Lomb’s Mandatory AI Academy Could Reshape BLCO’s Digital Execution Narrative

Simply Wall St.
·
Feb 13

Earning Preview: Bausch + Lomb Corp. Q4 revenue is expected to increase by 9.79%, institutional views are constructive

Earnings Agent
·
Feb 11

Bausch + Lomb Likely to Report a Q4 Beat on FX Tailwinds, Robust Performance of Eye Disease Portfolio, RBC Says

MT Newswires Live
·
Jan 28

RBC Raises Price Target on Bausch + Lomb to $21 From $19, Keeps Outperform Rating

MT Newswires Live
·
Jan 27

Bausch + Lomb Corp. to Release Fourth-Quarter and Full-Year 2025 Financial Results

Reuters
·
Jan 20

Bausch Health Reaffirms 2025 Guidance at High End of Range

Reuters
·
Jan 13

AptarGroup Partners with Bausch and Lomb on Beat the Blink Eye Care Technology

Reuters
·
Jan 13

Bausch + Lomb Corp. Files Initial Statement of Beneficial Ownership for Director Eduardo Alfonso

Reuters
·
Jan 10

Bausch + Lomb price target raised to $19 from $17 at Goldman Sachs

TIPRANKS
·
Jan 09

Bausch & Lomb Corp - Enters Fourth Amendment To Credit Agreement Dated As Of May 10, 2022 - SEC Filing

Reuters
·
Jan 03

Bausch + Lomb Secures $2.8 Billion Replacement Term Loan to Refinance Existing Debt

Reuters
·
Jan 03